Nithya Prasannan

Impaired exercise capacity in post–COVID-19 syndrome: the role of VWF-ADAMTS13 axis

M. Scully, Hakim-Moulay Dehbi, A. Doyle, 2022, Blood Advances.

Novel antiplatelet strategies targeting VWF and GPIb

M. Scully, Nithya Prasannan, 2020, Platelets.

A single 1 g/kg dose of intravenous immunoglobulin is a safe and effective treatment for immune thrombocytopenia; results of the first HaemSTAR ‘Flash‐Mob’ retrospective study incorporating 961 patients

Thomas G. Skinner, D. Halperin, C. Bradbury, 2021, British journal of haematology.

A HaemSTAR-led, UK-wide ‘flash-mob’ audit of ­intravenous immunoglobulin use in immune ­thrombocytopenia

Mohd Salleh Mohd Noh, Thomas G. Skinner, D. Halperin, 2019, Clinical Medicine.

A HaemSTAR-led, UK-wide 'flash-mob' audit of -intravenous immunoglobulin use in immune -thrombocytopenia.

Mohd Salleh Mohd Noh, Daniel J. Halperin, Thomas G. Skinner, 2019, Clinical medicine.

The use of obinutuzumab and ofatumumab in the treatment of immune thrombotic thrombocytopenic purpura

M. Scully, J. Westwood, W. Thomas, 2022, British journal of haematology.

Delayed normalisation of ADAMTS13 activity in acute Thrombotic Thrombocytopenic Purpura in the caplacizumab era.

M. Scully, J. Westwood, M. Thomas, 2023, Blood.